Cite
367P Detection of epidermal growth factor receptor mutations (EGFR-mut) from cell-free DNA in pleural effusion (PE-DNA) of patients with non-small cell lung cancer (NSCLC).
MLA
Lee, K. W. C., et al. “367P Detection of Epidermal Growth Factor Receptor Mutations (EGFR-Mut) from Cell-Free DNA in Pleural Effusion (PE-DNA) of Patients with Non-Small Cell Lung Cancer (NSCLC).” Annals of Oncology, vol. 31, Nov. 2020, pp. S1382–83. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.10.360.
APA
Lee, K. W. C., Lau, Y.-M., Mok, T., Chan, V. W. Y., Li, S. C., Chan, O. S. H., Kwong, T. C., Lo, P. Y., & Gai, W. (2020). 367P Detection of epidermal growth factor receptor mutations (EGFR-mut) from cell-free DNA in pleural effusion (PE-DNA) of patients with non-small cell lung cancer (NSCLC). Annals of Oncology, 31, S1382–S1383. https://doi.org/10.1016/j.annonc.2020.10.360
Chicago
Lee, K.W.C., Y-M. Lau, T. Mok, V.W.Y. Chan, S.C. Li, O.S.H. Chan, T.C. Kwong, P.Y. Lo, and W. Gai. 2020. “367P Detection of Epidermal Growth Factor Receptor Mutations (EGFR-Mut) from Cell-Free DNA in Pleural Effusion (PE-DNA) of Patients with Non-Small Cell Lung Cancer (NSCLC).” Annals of Oncology 31 (November): S1382–83. doi:10.1016/j.annonc.2020.10.360.